Approach to the hypophosphatemic patient
- PMID: 22392950
- PMCID: PMC3319220
- DOI: 10.1210/jc.2011-1319
Approach to the hypophosphatemic patient
Abstract
Hypophosphatemia is commonly missed due to nonspecific signs and symptoms, but it causes considerable morbidity and in some cases contributes to mortality. Three primary mechanisms of hypophosphatemia exist: increased renal excretion, decreased intestinal absorption, and shifts from the extracellular to intracellular compartments. Renal hypophosphatemia can be further divided into fibroblast growth factor 23-mediated or non-fibroblast growth factor 23-mediated causes. Proper diagnosis requires a thorough medication history, family history, physical examination, and assessment of renal tubular phosphate handling to identify the cause. During the past decade, our understanding of phosphate metabolism has grown greatly through the study of rare disorders of phosphate homeostasis. Treatment of hypophosphatemia depends on the underlying disorder and requires close biochemical monitoring. This article illustrates an approach to the hypophosphatemic patient and discusses normal phosphate metabolism.
Figures
Similar articles
-
Phosphate wasting disorders in adults.Osteoporos Int. 2018 Nov;29(11):2369-2387. doi: 10.1007/s00198-018-4618-2. Epub 2018 Jul 16. Osteoporos Int. 2018. PMID: 30014155 Review.
-
Hypophosphatemia: an evidence-based problem-solving approach to clinical cases.Iran J Kidney Dis. 2010 Jul;4(3):195-201. Iran J Kidney Dis. 2010. PMID: 20622306 Review.
-
Phosphatonins: From Discovery to Therapeutics.Endocr Pract. 2023 Jan;29(1):69-79. doi: 10.1016/j.eprac.2022.09.007. Epub 2022 Oct 7. Endocr Pract. 2023. PMID: 36210014 Review.
-
Dipyridamole for renal phosphate leak in successfully renal transplanted hypophosphatemic patients.Clin Nephrol. 2005 Feb;63(2):87-91. doi: 10.5414/cnp63087. Clin Nephrol. 2005. PMID: 15732176 Clinical Trial.
-
Metabolic aspects of phosphate replacement therapy for hypophosphatemia after renal transplantation: impact on muscular phosphate content, mineral metabolism, and acid/base homeostasis.Am J Kidney Dis. 1999 Nov;34(5):875-83. doi: 10.1016/S0272-6386(99)70045-4. Am J Kidney Dis. 1999. PMID: 10561144 Clinical Trial.
Cited by
-
Phosphaturic Mesenchymal Tumor of the Greater Trochanter: A Case Report.Cureus. 2024 Oct 2;16(10):e70721. doi: 10.7759/cureus.70721. eCollection 2024 Oct. Cureus. 2024. PMID: 39493128 Free PMC article.
-
The transcription factor BBX regulates phosphate homeostasis through the modulation of FGF23.Exp Mol Med. 2024 Nov 1. doi: 10.1038/s12276-024-01341-9. Online ahead of print. Exp Mol Med. 2024. PMID: 39482539
-
Nomogram for predicting early hypophosphatemia in term infants.BMC Pediatr. 2024 Apr 16;24(1):255. doi: 10.1186/s12887-024-04737-8. BMC Pediatr. 2024. PMID: 38627752 Free PMC article.
-
Diuretic Use and Serum Phosphate: Rotterdam Study and UK Biobank.J Endocr Soc. 2024 Mar 25;8(5):bvae057. doi: 10.1210/jendso/bvae057. eCollection 2024 Mar 12. J Endocr Soc. 2024. PMID: 38572420 Free PMC article.
-
Tumor-Induced Osteomalacia in a Patient with Crohn's Disease: A Case Report and Approach to Investigating Hypophosphatemia.Case Rep Gastroenterol. 2024 Feb 26;18(1):81-89. doi: 10.1159/000536136. eCollection 2024 Jan-Dec. Case Rep Gastroenterol. 2024. PMID: 38410687 Free PMC article.
References
-
- Liamis G, Milionis HJ, Elisaf M. 2010. Medication-induced hypophosphatemia: a review. QJM 103:449–459 - PubMed
-
- Soldin SJ, Hunt C, Hicks JM. 1999. Pediatric reference ranges for phosphorus on the Vitros 500 Analyzer. Clin Chem 45:A22 (abstract)
-
- Shiber JR, Mattu A. 2002. Serum phosphate abnormalities in the emergency department. J Emerg Med 23:395–400 - PubMed
-
- Laaban JP, Marsal L, Waked M, Vuong TK, Rochemaure J. 1990. Seizures related to severe hypophosphataemia induced by mechanical ventilation. Intensive Care Med 16:135–136 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
